RecruitingPhase 3NCT07325292
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
Sponsor: Sanofi
Atlanta, GA · Smyrna, GA · +32 more sites
Multiple Sclerosis clinical trials in Atlanta, GA
11 recruiting multiple sclerosis studies with a site in Atlanta, GA.
RecruitingPhase 1NCT03816345
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Sponsor: National Cancer Institute (NCI)
Atlanta, GA · +50 more sites
RecruitingPhase 4NCT07609719
A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
Sponsor: Genentech, Inc.
Atlanta, GA · +3 more sites
RecruitingPhase 2NCT07840326
A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
Sponsor: Sundance Biosciences, Inc.
Atlanta, GA · +2 more sites
RecruitingPhase not listedNCT06433752
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Atlanta, GA · Savannah, GA · +106 more sites
RecruitingPhase 3NCT05877963
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Sponsor: TG Therapeutics, Inc.
Atlanta, GA · Savannah, GA · +38 more sites
RecruitingPhase 2NCT07002034
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Sponsor: Reunion Neuroscience Inc
Atlanta, GA · +31 more sites
RecruitingNot applicableNCT06796504
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
Sponsor: SetPoint Medical Corporation
Atlanta, GA · +8 more sites
RecruitingNot applicableNCT06919900
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
Sponsor: Georgia State University
Atlanta, GA
RecruitingEarly Phase 1NCT06629428
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
Sponsor: Georgia State University
Atlanta, GA
RecruitingNot applicableNCT06495138
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
Sponsor: Emory University
Atlanta, GA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.